6-Dimethylamino-2'-deoxyguanosine (also known as 2-Amino-2’-deoxy-N6,N6-dimethyl-2’-adenosine) is a purine nucleoside analog with broad antitumor activity, particularly targeting indolent lymphoid malignancies. Its anticancer mechanism involves inhibition of DNA synthesis and induction of apoptosis.